HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cyclosporin treatment in steroid-resistant and acutely exacerbated interstitial pneumonia.

AbstractOBJECTIVE:
The aim of this study was to evaluate the efficacy of cyclosporin A (CsA) in patients with interstitial pneumonia (IP).
DESIGN:
Retrospective comparative study.
PATIENTS:
We reviewed 33 patients (23 males and 10 females with a mean age of 62.5 years) with histologically-proven progressive IP who were treated with CsA. All patients had corticosteroid-resistant IP or developed acute exacerbation of IP in their courses.
RESULTS:
The underlying systemic diseases were: idiopathic interstitial pneumonias (IIPs) in 19 patients, and collagen vascular diseases (CVDs) in 14. The histopathological patterns and underlying diseases of IP were classified as usual interstitial pneumonia (UIP)/idiopathic pulmonary fibrosis (IPF) in 10 patients, cellular-nonspecific interstitial pneumonia (NSIP)/IIPs in 3, fibrotic-NSIP/IIPs in 5, organizing pneumonia (OP)/IIP in 1, UIP/CVDs in 4, cellular-NSIP/CVDs in 7, fibrotic-NSIP/CVDs in 2, and diffuse alveolar damage (DAD)/CVD in 1, respectively. They received a low dosage of CsA combined with corticosteroids. The prognoses after treatment with CsA were well correlated with histopathological patterns. Cellular-NSIP and OP showed better prognoses than fibrotic-NSIP, UIP or DAD. In addition, CVDs had better prognoses than IIPs, when compared on the basis of the same histopathological patterns. Furthermore, the prognoses in the CsA-treated group were significantly better than in those without CsA treatment in regard to acute exacerbation of UIP/IPF.
CONCLUSIONS:
CsA combined with corticosteroids may be an efficacious treatment for corticosteroid-resistant IP and for acute exacerbation of IPF.
AuthorsSakae Homma, Susumu Sakamoto, Masateru Kawabata, Kazuma Kishi, Eiyasu Tsuboi, Noriko Motoi, Kunihiko Yoshimura
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 44 Issue 11 Pg. 1144-50 (Nov 2005) ISSN: 0918-2918 [Print] Japan
PMID16357451 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glucocorticoids
  • Immunosuppressive Agents
  • Cyclosporine
Topics
  • Acute Disease
  • Aged
  • Cyclosporine (therapeutic use)
  • Drug Resistance
  • Female
  • Follow-Up Studies
  • Glucocorticoids (adverse effects)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Lung Diseases, Interstitial (diagnosis, drug therapy, mortality)
  • Male
  • Middle Aged
  • Respiratory Function Tests
  • Retrospective Studies
  • Survival Rate
  • Tomography, X-Ray Computed
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: